179 related articles for article (PubMed ID: 30334525)
1. Angio-Computed Tomograph-Guided Immediate Lipiodol Computed Tomograph for Diagnosis of Small Hepatocellular Carcinoma Lesions during Transarterial Chemoembolization.
Liu FY; Li X; Yuan HJ; Guan Y; Wang MQ
Chin Med J (Engl); 2018 Oct; 131(20):2410-2416. PubMed ID: 30334525
[TBL] [Abstract][Full Text] [Related]
2. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT.
Chen R; Geschwind JF; Wang Z; Tacher V; Lin M
J Vasc Interv Radiol; 2013 Dec; 24(12):1837-44. PubMed ID: 24094672
[TBL] [Abstract][Full Text] [Related]
4. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
[No Abstract] [Full Text] [Related]
6. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
[TBL] [Abstract][Full Text] [Related]
7. Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.
Najmi Varzaneh F; Pandey A; Aliyari Ghasabeh M; Shao N; Khoshpouri P; Pandey P; Zarghampour M; Fouladi D; Liddell R; Anders RA; Kamel IR
Eur Radiol; 2018 Jul; 28(7):3032-3040. PubMed ID: 29383518
[TBL] [Abstract][Full Text] [Related]
8. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization.
Yang L; Zhang XM; Zhou XP; Tang W; Guan YS; Zhai ZH; Dong GL
J Vasc Interv Radiol; 2010 Dec; 21(12):1841-6. PubMed ID: 20980165
[TBL] [Abstract][Full Text] [Related]
9. Warming effect on miriplatin-lipiodol suspension as a chemotherapeutic agent for transarterial chemoembolization for hepatocellular carcinoma: preliminary clinical experience.
Kora S; Urakawa H; Mitsufuji T; Osame A; Higashihara H; Yoshimitsu K
Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1023-9. PubMed ID: 23238851
[TBL] [Abstract][Full Text] [Related]
10. Lipiodol as a Predictive Indicator for Therapy Response to Transarterial Chemoembolization of Hepatocellular Carcinoma.
Langenbach MC; Vogl TJ; Said G; Scholtz JE; Hammerstingl R; Gruber-Rouh T
Cancer Biother Radiopharm; 2024 Apr; 39(3):196-202. PubMed ID: 33481646
[No Abstract] [Full Text] [Related]
11. Dual phase cone-beam computed tomography in detecting <3 cm hepatocellular carcinomas during transarterial chemoembolization.
Wang X; Yarmohammadi H; Cao G; Ji X; Hu J; Yarmohammadi H; Chen H; Zhu X; Yang R; Solomon SB
J Cancer Res Ther; 2017; 13(1):38-43. PubMed ID: 28508831
[TBL] [Abstract][Full Text] [Related]
12. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response.
Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X
Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376
[TBL] [Abstract][Full Text] [Related]
13. Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response.
Dioguardi Burgio M; Sartoris R; Libotean C; Zappa M; Sibert A; Vilgrain V; Ronot M
Cancer Imaging; 2019 Nov; 19(1):75. PubMed ID: 31730491
[TBL] [Abstract][Full Text] [Related]
14. Cone-Beam Computed Tomography Correlates with Conventional Helical Computed Tomography in Evaluation of Lipiodol Accumulation in HCC after Chemoembolization.
Ishikawa T; Abe S; Hoshii A; Yamada Y; Iiduka A; Nemoto T; Takeda K; Yoshida T
PLoS One; 2016; 11(1):e0145546. PubMed ID: 26752696
[TBL] [Abstract][Full Text] [Related]
15. Spectral CT in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma: A retrospective study.
Wang J; Shen JL
Medicine (Baltimore); 2017 Dec; 96(52):e9236. PubMed ID: 29384909
[TBL] [Abstract][Full Text] [Related]
16. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria.
Shim JH; Han S; Shin YM; Yu E; Park W; Kim KM; Lim YS; Lee HC
J Vasc Interv Radiol; 2013 Mar; 24(3):316-25. PubMed ID: 23312990
[TBL] [Abstract][Full Text] [Related]
17. Improved Local Tumor Control and Survival Rates by Obtaining a 3D-Safety Margin in Superselective Transarterial Chemoembolization for Small Hepatocellular Carcinoma.
Kattipatanapong T; Nishiofuku H; Tanaka T; Sato T; Masada T; Tatsumoto S; Matsumoto T; Kichikawa K
Cardiovasc Intervent Radiol; 2020 Mar; 43(3):423-433. PubMed ID: 31720806
[TBL] [Abstract][Full Text] [Related]
18. Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome.
Herber S; Biesterfeld S; Franz U; Schneider J; Thies J; Schuchmann M; Düber C; Pitton MB; Otto G
Cardiovasc Intervent Radiol; 2008; 31(4):768-77. PubMed ID: 18196335
[TBL] [Abstract][Full Text] [Related]
19. Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
Zhang L; Sun JH; Ji JS; Zhong BY; Zhou GH; Song JJ; Hou ZH; Huang P; Zhang S; Li Z; Zhu XL; Ni CF
AJR Am J Roentgenol; 2021 Oct; 217(4):933-943. PubMed ID: 33245680
[No Abstract] [Full Text] [Related]
20. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
